CDKN2A and melanoma: In sporadic melanomas, various genetic alterations of p16 have been reported, such as point mutations (0–26%), promoter methylation (0–19%), and homozygous deletions (6–25%)(Rocco and Sidransky, 2001; Straume et al, 2002).